▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒Executive summary

Prior-authorization agents need an authorization-yield ledger: proof, by payer and service line, that AI turns policy, chart evidence and status telemetry into cleaner approvals, clearer denial reasons and stronger appeals without shifting risk to clinicians or patients. Revenue-cycle leaders should fund prior-authorization AI where it closes the denial feedback loop. The product requirement is an auditable record of policy version, chart evidence, submission channel, status, denial reason, appeal action, recovered revenue, reviewer minutes and patient delay.

CMS-0057-F and Da Vinci PAS make request and status workflow testable ¹⁴; the 2026 drug proposal extends the question into medication lanes ². Those rules set the test, then local telemetry decides whether clean-submission rate, status cycle time and denial yield improve by payer.

Outside the U.S., keep the same yield-loop test but replace CMS/PAS assumptions with local authorization channel, response-clock, appeal and documentation duties before procurement.

The trap is front-end speed without back-end learning. KFF's Medicare Advantage data makes the appeal denominator impossible to ignore: most appealed denials were at least partly overturned in 2024, so a system that does not raise appeal filing quality or overturn yield is leaving value and access risk unmeasured ¹³.

The first production lane should be the revenue or care-delay pocket with observable outcomes: a few payer and service-line pairs measured on clean approval, denial-reason capture, appeal yield, recovered revenue and patient-delay events ¹³. Separately baseline electronic-channel success ¹⁵ and reviewer-minute savings ¹⁶ before accepting ROI claims. Move attachment completeness and reassociation into lane-level acceptance tests ¹⁷.

Make the ledger a contract deliverable: payer, service line, benefit, policy version, evidence fields, channel, response clock, denial reason, appeal filed, appeal overturn, reviewer action and exportable audit trail.

Scale only when net accepted output improves by payer. A vendor that lifts submission volume while raising denials, appeals or hidden clinician work is moving the bottleneck.

The buying decision

Question	Answer	Action
What is the object of approval?	A payer, service-line and request-type yield register.	Make source, status, attachment, denial, appeal filing, appeal overturn and telemetry fields contract deliverables before volume expansion.
Which lane goes first?	A high-volume payer and service-line pair with avoidable denials or delays and stable policy requirements.	Baseline clean-submission rate, status cycle time, denial reasons, appeal yield, reviewer minutes and patient delays.
What remains blocked?	Autonomous adverse medical-necessity decisions, stale-policy packet drafting and staffing reductions before accepted-output telemetry.	Keep reviewer authority and appeal evidence in place until local metrics prove the expansion.

▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒What changed

Public evidence is now structured enough to define private approval tests. The trigger is payer-specific operating proof: endpoint readiness, policy freshness, attachment completeness, denial-reason capture and appeal yield. Treat CMS and drug-rule timing as external pressure, then let payer/service-line telemetry decide spend ¹². Public appeal data supplies the denominator for the denial-feedback test ¹³. The value is the payer-by-payer learning loop: which requests become clean approvals, avoidable denials, appeals, delayed care or write-offs. CMS and Da Vinci make submission and status testable ¹⁴; MA and state evidence keep denial authority and appeal records in a reviewed lane ⁵⁷.

Start where denied or delayed revenue concentrates: choose a few payer and service-line lanes, baseline clean-submission rate, electronic-channel success, attachment completeness, status-cycle time, denial reason, appeal filing, appeal overturn, reviewer minutes and patient-delay events, then expand only when the agent improves the loop ¹³¹⁵.

For high-risk workflows, the approval record has to connect source evidence, accepted output, reviewer action, exception path, outcome signal and retained audit record before volume or staffing claims matter.

Triggers that change approval timing

Trigger	Why it matters	Decision use
CMS-0057-F API compliance ¹	The payer-provider authorization workflow is becoming an API, response-clock and public-metrics requirement ¹¹².	Map current portal and fax work to CMS response expectations ¹² and PAS request, status, update and cancellation paths ⁴.
Drug prior-authorization proposal ²	Medication workflows may gain medical-benefit and pharmacy-benefit standards, response-time and transparency obligations ².	Separate drug authorization lanes by benefit type, payer channel and decision-time obligation.
Utilization-management oversight ⁵⁶	MA rules make UM committees, health-equity analysis and public posting more visible ⁵⁶.	Use state human-oversight guidance to keep reviewer accountability, policy evidence and appeal telemetry in the lane ⁷.
CAQH electronic-adoption gap ¹⁵¹⁶	Prior authorization remains partly manual even as CMS pushes API workflows, so channel mix and attachment handling can decide whether automation reduces work.	Baseline electronic-channel success, portal fallback and reviewer minutes before accepting ROI claims; test attachment completeness separately ¹⁷.

▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒Decision map

Workflow approval changes by authority, source boundary and proof burden. Start with payer-by-payer proof that AI improves clean approvals, denial handling and appeals before staff or cash assumptions move. The decision map should start with a payer-by-payer authorization loop from live policy and chart evidence to submission, status, denial reason, appeal outcome and cash or care-delay result: what source record is read, what output is drafted, who approves it, where it is stored and what event forces reapproval.

A system can pass a low-risk support test and still fail production work: source evidence, accepted output, integration state, exception handling, reviewer burden and downstream rework have to hold together.

The useful vendor question is whether the system can make the named task inspectable, reversible and measurable inside the operating record.

Workflow selection

Workflow	Accepted work	Approval gate	Approval rule
Payer-by-payer authorization yield	Clean request, status result, denial reason, appeal filing, appeal overturn or write-off result tied to payer, service line and request type.	Policy source, member context, EHR evidence, payer channel, response clock, attachment record and denial feedback are retained.	Pilot the lanes with the largest denied or delayed revenue before broad automation.
Chart evidence assembly	Chart-backed packet with required fields, attachments and clinical rationale.	EHR source references, missing-data queue and reviewer sign-off.	Measure accepted requests and rework before staff reduction claims.
Electronic submission and status	FHIR or payer-channel submission with status, update and cancellation path ¹⁴.	PAS conformance, payer endpoint, exception fallback and audit log ⁴.	Approve by payer endpoint, not as universal integration.
Denial and appeal intelligence	Cited denial reason, appeal draft, next-best evidence list and outcome feedback.	Qualified reviewer, appeal deadline, source citations and medical-necessity standard ¹⁴¹⁸.	Keep final adverse-coverage and appeal judgement with accountable clinical reviewers.

Write authority changes the proof burden

Source path

Reviewer gate

System action

Retest trigger

Payer-by-payer authorization yieldClean request, status result, denial reason, appeal filing, appeal overturn or write-off result tied to payer, service line and request type.

Source namedPolicy source, member context, EHR evidence, payer channel, response clock, attachment record and denial feedback are retained.

Human gatePilot the lanes with the largest denied or delayed revenue before broad automation.

Accepted workClean request, status result, denial reason, appeal filing, appeal overturn or write-off result tied to payer, service line and request type.

ReapprovalRetest when policy, workflow, model, data access or system write rights change.

Chart evidence assemblyChart-backed packet with required fields, attachments and clinical rationale.

Source namedEHR source references, missing-data queue and reviewer sign-off.

Human gateMeasure accepted requests and rework before staff reduction claims.

Accepted workChart-backed packet with required fields, attachments and clinical rationale.

ReapprovalRetest when policy, workflow, model, data access or system write rights change.

Electronic submission and statusFHIR or payer-channel submission with status, update and cancellation path ¹⁴.

Source namedPAS conformance, payer endpoint, exception fallback and audit log ⁴.

Human gateApprove by payer endpoint, not as universal integration.

Accepted workFHIR or payer-channel submission with status, update and cancellation path ¹⁴.

ReapprovalRetest when policy, workflow, model, data access or system write rights change.

Denial and appeal intelligenceCited denial reason, appeal draft, next-best evidence list and outcome feedback.

Source namedQualified reviewer, appeal deadline, source citations and medical-necessity standard ¹⁴¹⁸.

Human gateKeep final adverse-coverage and appeal judgement with accountable clinical reviewers.

Accepted workCited denial reason, appeal draft, next-best evidence list and outcome feedback.

ReapprovalRetest when policy, workflow, model, data access or system write rights change.

Private eval can start hereRequires named owner or reviewerHard approval gate before scale

Use the matrix to decide what proof is required before each workflow becomes accepted work.

▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒Glossary

Terms used in this report

Term	Plain meaning
Route	The approved path from work to accepted output: source set, data boundary, model or vendor channel, tools, reviewer, evidence record and reapproval trigger.
API	Application programming interface: a governed software connection used by an app or workflow to call a model or service.

Definitions are reader aids, not separate evidence claims.

AI agents for revenue cycle and prior authorization

The colophon

What the locked report contains